help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurlek, A.
Right arrow Articles by Kumar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurlek, A.
Right arrow Articles by Kumar, R.
Endocrine Reviews 23 (6): 763-786
Copyright © 2002 by The Endocrine Society

Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation

Alper Gurlek1, Mark R. Pittelkow and Rajiv Kumar

Departments of Medicine (A.G., R.K.), Dermatology (M.R.P.), and Biochemistry and Molecular Biology (M.R.P., R.K.), Mayo Clinic and Foundation, Rochester, Minnesota 55905

Correspondence: Address all correspondence and requests for reprints to: Rajiv Kumar, M.D., Departments of Medicine, Biochemistry and Molecular Biology, Mayo Clinic and Foundation, 200 First Street SW, 911A Guggenheim Building, Rochester, Minnesota 55905. E-mail: rkumar{at}mayo.edu

Distinct from its classic functions in the regulation of calcium and phosphorus metabolism as a systemic hormone, 1{alpha},25-dihydroxyvitamin D3 [1{alpha},25(OH)2D3] is involved in the local control and regulation of cellular growth and differentiation in various tissues, including epidermis (keratinocytes) and bone (osteoblasts and osteoclasts). In this review, the impact of 1{alpha},25(OH)2D3 on growth factor/cytokine synthesis and signaling is discussed, particularly as it pertains to bone cells and keratinocytes. 1{alpha},25(OH)2D3 not only regulates growth factor/cytokine synthesis but may also alter growth factor signaling. Recently discovered examples for such interactions are the interactions between the vitamin D receptor and the mothers against decapentaplegic-related proteins that function downstream of TGFß receptors. Inhibitory effects of 1{alpha},25(OH)2D3 on keratinocytes through TGFß activation and IL-1{alpha}, IL-6, and IL-8 suppression may provide a rationale for its beneficial effects in the treatment of hyperproliferative skin disorders, whereas stimulatory effects through the epidermal growth factor-related family members and platelet-derived growth factor may be operative in its beneficial effects in skin atrophy and wound healing. Modulation of cytokines and growth factors by 1{alpha},25(OH)2D3 during bone remodeling plays an important role in the coupling of osteoblastic bone formation with osteoclastic resorption to maintain bone mass.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
G. Jean, J.-C. Souberbielle, and C. Chazot
Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation
Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3799 - 3805.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Tokmak, I. Quack, G. Schieren, L. Sellin, D. Rattensperger, T. Holland-Letz, S. M. Weiner, and L. C. Rump
High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4016 - 4020.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Moeenrezakhanlou, L. Shephard, L. Lam, and N. E. Reiner
Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase
J. Leukoc. Biol., August 1, 2008; 84(2): 519 - 528.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs
Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. C. McCann and B. N. Ames
Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
FASEB J, April 1, 2008; 22(4): 982 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. J. Schedlich, A. Muthukaruppan, M. K. O'Han, and R. C. Baxter
Insulin-Like Growth Factor Binding Protein-5 Interacts with the Vitamin D Receptor and Modulates the Vitamin D Response in Osteoblasts
Mol. Endocrinol., October 1, 2007; 21(10): 2378 - 2390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Sun, J. Kong, Y. Duan, F. L. Szeto, A. Liao, J. L. Madara, and Y. C. Li
Increased NF-{kappa}B activity in fibroblasts lacking the vitamin D receptor
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E315 - E322.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Kong, S. A. Grando, and Y. C. Li
Regulation of IL-1 Family Cytokines IL-1{alpha}, IL-1 Receptor Antagonist, and IL-18 by 1,25-Dihydroxyvitamin D3 in Primary Keratinocytes
J. Immunol., March 15, 2006; 176(6): 3780 - 3787.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T.-T. Wang, L. E. Tavera-Mendoza, D. Laperriere, E. Libby, N. Burton MacLeod, Y. Nagai, V. Bourdeau, A. Konstorum, B. Lallemant, R. Zhang, et al.
Large-Scale in Silico and Microarray-Based Identification of Direct 1,25-Dihydroxyvitamin D3 Target Genes
Mol. Endocrinol., November 1, 2005; 19(11): 2685 - 2695.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Zhang, P. Li, J. Bao, S. V. Nicosia, H. Wang, S. A. Enkemann, and W. Bai
Suppression of Death Receptor-mediated Apoptosis by 1,25-Dihydroxyvitamin D3 Revealed by Microarray Analysis
J. Biol. Chem., October 21, 2005; 280(42): 35458 - 35468.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. L. M. Sutton, X. Zhang, T. I. Ellison, and P. N. MacDonald
The 1,25(OH)2D3-Regulated Transcription Factor MN1 Stimulates Vitamin D Receptor-Mediated Transcription and Inhibits Osteoblastic Cell Proliferation
Mol. Endocrinol., September 1, 2005; 19(9): 2234 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Galindo, J. Pratap, D. W. Young, H. Hovhannisyan, H.-J. Im, J.-Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen
The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts
J. Biol. Chem., May 27, 2005; 280(21): 20274 - 20285.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. M. Harris and V. L. W. Go
Vitamin D and Colon Carcinogenesis
J. Nutr., December 1, 2004; 134(12): 3463S - 3471S.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
O. Morales, M. K. R. Samuelsson, U. Lindgren, and L.-A. Haldosen
Effects of 1{alpha},25-Dihydroxyvitamin D3 and Growth Hormone on Apoptosis and Proliferation in UMR 106 Osteoblast-Like Cells
Endocrinology, January 1, 2004; 145(1): 87 - 94.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society